Using Telehealth at Syringe Service Programs to Connect People Who Inject Drugs to HIV Care
Comprehensive Telehealth at Syringe Service Programs to Engage People Who Inject Drugs into the HIV Care Continuum
['FUNDING_OTHER'] · UNIVERSITY OF MINNESOTA · NIH-11189765
This project helps people who inject drugs get connected to important HIV prevention and treatment, as well as opioid use disorder care, by offering telehealth services at syringe service programs.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MINNESOTA (nih funded) |
| Locations | 1 site (MINNEAPOLIS, UNITED STATES) |
| Trial ID | NIH-11189765 on ClinicalTrials.gov |
What this research studies
Many people who inject drugs face challenges getting care for HIV, hepatitis C, and opioid use disorder due to a complex healthcare system, difficult paperwork for social programs, and stigma. This project aims to make it easier by bringing telehealth services directly to syringe service programs, which are trusted places for many. By offering virtual appointments for HIV prevention (PrEP) and medication for opioid use disorder (MOUD) in these settings, we hope to overcome barriers and help more people stay connected to care. This approach uses technology to provide flexible and accessible health services where they are most needed.
Who could benefit from this research
Good fit: Ideal candidates for this type of intervention are people who inject drugs and face challenges accessing traditional healthcare for HIV, hepatitis C, or opioid use disorder.
Not a fit: Patients who already have consistent access to and are engaged in HIV and opioid use disorder care through traditional healthcare settings may not directly benefit from this specific intervention.
Why it matters
Potential benefit: If successful, this approach could make it much easier for people who inject drugs to access vital HIV prevention and treatment, as well as support for opioid use disorder, leading to better health outcomes.
How similar studies have performed: Telehealth has shown success in delivering various health services, and syringe service programs are known for effectively engaging people who inject drugs, suggesting a strong foundation for this combined approach.
Where this research is happening
MINNEAPOLIS, UNITED STATES
- UNIVERSITY OF MINNESOTA — MINNEAPOLIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SMITH, M KUMI — UNIVERSITY OF MINNESOTA
- Study coordinator: SMITH, M KUMI
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus